DOI: https://doi.org/10.22141/2224-0721.14.5.2018.143018

Giant pituitary adenomas: prevalence, features of diagnosis clinical course

Yu.M. Urmanova, K.B. Alimova

Abstract


Based on the review of the literature, it is established that in the diagnostic complex with giant pituitary ade­nomas, in addition to clinical examination, it is necessary to use a full range of neuroimaging methods with determination of the chiasm location, the degree of tumor spread to the base of the skull and destruction of the latter. Surgical treatment is the method of choice when establishing the diagnosis of the giant pituitary adenoma, except for isolated cases of growth hormone and prolactin secreting tumors, in which treatment with dopamine agonists is possible. In this case, giant pituitary adenomas (diameter more than 4 cm) are still a problem, and there is no agreement on the optimal surgical strategy.

Keywords


giant pituitary adenomas; diagnosis; treatment

References


Gruppetta M, Vassallo J. Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study. Clin Endocrinol (Oxf). 2016;85(2):223-31. doi: 10.1111/cen.13064.

Gruppetta M, Mercieca C, Vassallo J. Prevalence and incidence of pituitary adenomas: a population based study in Malta. Pituitary. 2013;16(4):545-53. doi: 10.1007/s11102-012-0454-0.

Raverot G, Burman P, McCormack AI, et al. European Society of Endocrinology clinical practice guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018 Jan;178(1):G1-G24. doi: 10.1530/EJE-17-0796.

Saeger W, Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S. Pathohistological classification of pituitary tumors: 10 years of experience with the German pituitary tumor registry. Eur J Endocrinol. 2007;156(2):203-216.  doi: 10.1530/eje.1.02326.

Lopes MBS. The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol. 2017 Oct;134(4):521-535. doi: 10.1007/s00401-017-1769-8.

Sanchez-Tejada L, Sanchez-Ortiga R, Lamas C, et al. Contribution of molecular analysis to the typification of the non-functioning pituitary adenomas. PLoS One. 2017 Jul 10;12(7):e0180039. doi: 10.1371/journal.pone.0180039.

Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol. 2017 Sep;28(3):228-243. doi: 10.1007/s12022-017-9498-z.

Graillon T, Castinetti F, Fuentes S, et al. Transcranial approach in giant pituitary adenomas: results and outcome in a modern series. J Neurosurg Sci. 2017 Jan 12. doi: 10.23736/S0390-5616.16.03889-3.

Yosef L, Ekkehard KM, Shalom M. Giant craniopharyngiomas in children: short- and long-term implications. Childs Nerv Syst. 2016;32(1):79-88. doi: 10.1007/s00381-015-2961-6.

Espinosa E, Sosa E, Mendoza V, Ramírez C, Melgar V, Mercado M. Giant prolactinomas: are they really different from ordinary macroprolactinomas? Endocrine. 2016;52(3):652-9. doi: 10.1007/s12020-015-0791-7.

Zakir JC, Casulari LA, Rosa JW, et al. Prognostic Value of Invasion, Markers of Proliferation, and Classification of Giant Pituitary Tumors, in a Georeferred Cohort in Brazil of 50 Patients, with a Long-Term Postoperative Follow-Up. Int J Endocrinol. 2016;2016:7964523. doi: 10.1155/2016/7964523.

Landeiro JA, Fonseca EO, Monnerat AL, Taboada GF, Cabral GA, Antunes F. Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence. Surg Neurol Int. 2015;6:179. doi: 10.4103/2152-7806.170536.

Chohan MO, Levin AM, Singh R, et al. Three-dimensional volumetric measurements in defining endoscope-guided giant adenoma surgery outcomes. Pituitary. 2016;19(3):311-21. doi: 10.1007/s11102-016-0709-2.

Han S, Gao W, Jing Z, Wang Y, Wu A. How to deal with giant pituitary adenomas: transsphenoidal or transcranial, simultaneous or two-staged? J Neurooncol. 2017;132(2):313-321. doi: 10.1007/s11060-017-2371-6.

Cappabianca P, Cavallo LM, de Divitiis O, de Angelis M, Chiaramonte C, Solari D. Endoscopic Endonasal Extended Approaches for the Management of Large Pituitary Adenomas. Neurosurg Clin N Am. 2015;26(3):323-31. doi: 10.1016/j.nec.2015.03.007.

Nishioka H, Hara T, Nagata Y, Fukuhara N, Yamaguchi-Okada M, Yamada S. Inherent Tumor Characteristics That Limit Effective and Safe Resection of Giant Nonfunctioning Pituitary Adenomas. World Neurosurg. 2017;106:645-652. doi: 10.1016/j.wneu.2017.07.043.

Omodaka S, Ogawa Y, Sato K, Matsumoto Y, Tominaga T. Preoperative embolization and immediate removal of a giant pituitary adenoma: a case report. MC Res Notes. 2017;10(1):63. doi: 10.1186/s13104-017-2383-5.

Patil CG, Veeravagu A, Prevedello DM. Outcomes after repeat transsphenoidal surgery for recurrent Cushing’s disease. Neurosurgery. 2008 Aug;63(2):266-70; discussion 270-1. doi: 10.1227/01.NEU.0000313117.35824.9F.

Yano S, Hide T, Shinojima N. Efficacy and Complications of Endoscopic Skull Base Surgery for Giant Pituitary Adenomas. World Neurosurg. 2017;99:533-542. doi: 10.1016/j.wneu.2016.12.068.




Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта